Skaneateles Falls, NY — Welch Allyn announced that Greg Norden and Craig B. Reynolds have been elected by Welch Allyn shareholders to serve on its Board of Directors.
Norden and Reynolds join nine incumbent directors, including Chairman of the Board James Crook Jr, and Welch Allyn President and CEO Julie Shimer.
Norden brings a proven background in finance and more than 20 years of experience as a senior executive in the global health care and pharmaceutical industries. He served as senior vice president and CFO of Wyeth (formerly American Home Products Corp), prior to Pfizer’s acquisition of Wyeth in 2009. Before joining Wyeth, Norden worked in audit management at Arthur Andersen & Co, where he managed major audit engagements for top corporations. Norden is currently a director of Human Genome Sciences Inc, a biopharmaceutical company.
Reynolds joins the Welch Allyn Board with a 30-year track record in health care. He is a former chief operating officer and director of Respironics Inc, a maker of medical devices to diagnose and treat obstructive sleep apnea. When Philips Electronics acquired Respironics in 2008, Reynolds served as Philips’ executive vice president and COO of the Home Healthcare Solutions. Before he joined Respironics, Reynolds held various key positions, including CEO and president, during a 17-year career at Healthdyne Technologies Inc, a manufacturer of advanced devices to diagnose and treat medical conditions including sleep and breathing disorders. Reynolds currently serves as chairman of the Board of Directors of Symmetry Medical Inc, a provider of implants and related instruments and cases to global orthopedic device manufacturers.
Other current Welch Allyn board members are fourth generation family members Eric Allyn, Tasha Allyn Given and Peer Allyn Soderberg, MD, as well as Robert J. Bennett, Larry Buckelew, Yvonne Curl, and Barry Wilson.
SOURCE: Welch Allyn